189 related articles for article (PubMed ID: 940284)
21. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
Beckerhoff R; Uhlschmid G; Vetter W; Armbruster H; Nussberger J; Reck G; Schmied U; Siegenthaler W
Clin Sci Mol Med Suppl; 1975 Jun; 2():41s-44s. PubMed ID: 1077788
[TBL] [Abstract][Full Text] [Related]
22. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
[TBL] [Abstract][Full Text] [Related]
23. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
Ibsen H; Kappelgaard AM; Nielsen MD; Giese J
Eur J Clin Pharmacol; 1978 Nov; 14(3):171-6. PubMed ID: 729612
[No Abstract] [Full Text] [Related]
24. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
25. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
26. The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
Vetter W; Vetter H; Beckerhoff R; Redlich B; Cottier P; Siegenthaler W
Klin Wochenschr; 1976 Jul; 54(14):661-3. PubMed ID: 979066
[TBL] [Abstract][Full Text] [Related]
27. The effects of angiotensin II blockade and nephrectomy on the renin-angiotensin-aldosterone system in the newborn lamb.
Siegel SR; Fisher DA
Pediatr Res; 1979 May; 13(5 Pt 1):603-5. PubMed ID: 471592
[TBL] [Abstract][Full Text] [Related]
28. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
MacGregor GA; Dawes PM
Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Van Hoogdalem P; Donker AJ; Leenen FH
Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
[TBL] [Abstract][Full Text] [Related]
30. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II blockade in normal subjects and essential hypertensive patients.
MacGregor GA; Dawes PM
Clin Sci Mol Med Suppl; 1976 Dec; 3():193s-196s. PubMed ID: 1071606
[TBL] [Abstract][Full Text] [Related]
32. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
[TBL] [Abstract][Full Text] [Related]
33. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
34. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
Waks UA; Maxwell MH; Marks L; Zawada ET; Kaufman JJ
Circulation; 1978 Jun; 57(6):1165-70. PubMed ID: 639240
[TBL] [Abstract][Full Text] [Related]
35. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
Macdonald GJ; Boyd GW; Peart WS
Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
[TBL] [Abstract][Full Text] [Related]
36. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin blockade in studies of the feedback control of renin release in rats and rabbits.
Stokes GS; Oates HF; Weber MA
Clin Sci Mol Med Suppl; 1975 Jun; 2():33s-36s. PubMed ID: 1077786
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacology of angiotensin antagonists.
Pettinger WA; Mitchell HC
Fed Proc; 1976 Nov; 35(13):2521-5. PubMed ID: 976494
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II blockade in patients with essential hypertension.
MacGregor GA; Dawes PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
[TBL] [Abstract][Full Text] [Related]
40. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion.
Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
Prog Biochem Pharmacol; 1976; 12():53-62. PubMed ID: 1019170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
